Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001239648-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-11 | ANAB | LOUMEAU ERIC J | CLO | M - OptEx | $29.70 | +10.0K | 22.8K | +78% | +$297.0K |
| D | 2026-02-13 | 2026-02-11 | ANAB | LOUMEAU ERIC J | CLO | S - Sale+OE | $54.00 | -10.0K | 12.8K | -44% | -$540.0K |
| D | 2026-02-13 | 2026-02-11 | ANAB | LOUMEAU ERIC J | CLO | M - OptEx | $0.00 | -10.0K | 35.0K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-11 | M | A | 10,000 | $29.70 | 22,835 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-11 | S | D | 10,000 | $54.00 | 12,835 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2026-02-11 | M | D | 10,000 | $0.00 | 35,000 | D | $29.70 · — to 2031-02-09 | 10,000 Common Stock | (F3) In addition to the options to purchase a total of 35,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 436,010 shares of common stock, which options vest according to their terms. (F2) The stock option is fully vested. |